国产日韩久久,久久精品视频8,91丨九色丨蝌蚪丰满

Adipokinetic hormoneprecursor-related peptide 1 (Schistocerca gregaria reduced) (9CI);
Adipokinetichormone precursor-related peptide 2 (Schistocerca gregaria a-chain reduced);
L-Asparagine, L-a-aspartyl-L-alanyl-L-alanyl-L-a-aspartyl-L-phenylalanylglycyl-L-a-aspartyl-L-prolyl-L-tyrosyl-L-seryl-L-phenylalanyl-L-leucyl-L-tyrosyl-L-arginyl-L-leucyl-L-isoleucyl-L-glutaminyl-L-alanyl-L-a-glutamyl-L-alanyl-L-arginyl-L-lysyl-L-methionyl-L-serylglycyl-L-cysteinyl-L-seryl-;
Protein (Schistocerca gregaria prepro-adipokinetic hormone I C-terminal a-chain)

C136H205N37O44S2

詳情

供應商

157214-61-4

Protegrin 4 (9CI);
L-Argininamide,L-arginylglycylglycyl-L-arginyl-L-leucyl-L-cysteinyl-L-tyrosyl-L-cysteinyl-L-arginylglycyl-L-tryptophyl-L-isoleucyl-L-cysteinyl-L-valyl-L-cysteinyl-L-valylglycyl-,cyclic (6®
15),(8®
13)-bis(disulfide);
Protegrin 4 (swine precursor);
Protegrin PG 4 (pig reduced);
Protegrin PG 4 (swine reduced);
Protegrin PG-4(pig strain Duroc bone marrow cell)

1,2,4-Triazolidine-3,5-dione,4-[4-(6-methoxy-2-benzoxazolyl)phenyl]-;
4-[4-(6-METHOXY-2-BENZOXAZOLYL)PHENYL]-1,2,4-TRIAZOLIDINE-3,5-DIONE;
MBOTAD precursor;
4-(4-(6-methoxy-2-benzoxazolyl)*phenyl)-1,2,4-tri;
4-(4-(6-METHOXY-2-BENZOXAZOLYL)*PHENYL)- 1,2,4-TRIAZ

13,6-(Epithioimino)pentacene-16-carboxylicacid, 6,13-dihydro-, butyl ester, 15-oxide (9CI);
Pentacene-N-sulfinyl-n-butylcarbamate adduct;
Soluble pentacene precursor, 6,13-Dihydro-13,6-(epithioimino)pentacene-16-carboxylic acid, butyl ester, 15-oxide

APELIN precursor (61-77) (HUMAN, BOVINE, MOUSE, RAT) TRIFLUOROACETATE;
H-LYS-PHE-ARG-ARG-GLN-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE-OH TRIFLUOROACETATE;
APELIN-17 (HUMAN, BOVINE, MOUSE, RAT) TRIFLUOROACETATE;
APELIN precursor (61-77) (HUMAN, BOVINE, MOUSE, RAT) TRIFLUOROACETATE;
PREPROAPELIN (61-77) (HUMAN, BOVINE, MOUSE, RAT) TRIFLUOROACETATE

BOC保護的胸苷

1-(2'-DEOXY-3'-O-(4-NITROBENZENESULFONYL)-5'-O-(4,4'-DIMETHOXYTRITYL)-BETA-D-THREO-PENTAFURANOSYL)-3;
BOC-FLT;
3-N-BOC-5'-O-DIMETHOXYTRITYL-3'-O-NOSYL-THYMIDINE;
3-N-BOC-1-[5-O-(4,4'-DIMETHOXYTRITYL)-3-O-NITROPHENYLSULFONYL-2-DEOXY-E-D-LYXOFURANOSYL]THYMIDINE;
1-(2'-DEOXY-3'-O-(4-NITROBENZENESULFONYL)-5'-O-(4,4'-DIMETHOXYTRITYL)-BETA-D-THREO-PENTAFURANOSYL)-3-(TERT-BUTYLOXYCARBONYL)THYMINE;
1(2H)-Pyrimidinecarboxylic acid, 3-[2-deoxy-3-O-[(4-nitrophenyl)sulfonyl]-5-O-(triphenylmethyl)-beta-D-threo-pentofuranosyl]-3,6-dihydro-5-methyl-2,6-dioxo-, 1,1-dimethylethyl ester;
1-(2'-Deoxy-3'-O-(4-nitrobenzenesulfonyl)-5'-O-(4,4'-dimethoxytrityl)- beta-D-threo-pentafuranosyl)-3-(tert-butyloxycarbonyl)thymine;
3-N-Boc-5'-O-dimethoxytrityl-3'-O-nosyl-thymidine 3-N-Boc-1-[5-O-(4,4'-dimethoxytrityl)-3-O-nitrophenylsulfonyl-2-deoxy-beta-D-lyxofuranosyl]thymidine;
Boc-FLT-precursor

CYS-GLN-ASP-SER-GLU-THR-ARG-THR-PHE-TYR

CYS-GLN-ASP-SER-GLU-THR-ARG-THR-PHE-TYR;
FIBRONECTIN precursor (561-599), MOUSE, RAT;
FIBRONECTIN (530-568), BOVINE;
H-CYS-GLN-ASP-SER-GLU-THR-ARG-THR-PHE-TYR-OH;
CYS-GLN-ASP-SER-GLU-THR-ARG-THR-PHE-TYR;
CQDSETDTFY;
CQDSETRTFY;
COLLAGEN BINDING FRAGMENT;
CYS-GLN-ASP-SER-GLU-THR-ARG-THR-PHE-(CYS-GLN-ASP-SER-GLU-THR-ARG-THR-PHE-TYR)

2,4(1H,3H)-PYRIMIDINEDIONE,1-[5-O-[BIS(4-METHOXYPHENYL)PHENYLMETHYL]-2-DEOXY-3-O-[(4-NITROPHENYL)SUL;
N-(2,4-DIMETHOXYBENZYL)-5'-O-DIMETHOXYTRITYL-3'-O-NOSYL-THYMIDINE;
3-N-(2,4-DIMETHOXYBENZYL)-1-[5-O-(4,4'-DIMETHOXYTRITYL)-3-O-NITROPHENYLSULFONYL-2-DEOXY-BETA-D-LYXOFURANOSYL]THYMIDINE;
2,4(1H,3H)-PYRIMIDINEDIONE,1-[5-O-[BIS(4-METHOXYPHENYL)PHENYLMETHYL]-2-DEOXY-3-O-[(4-NITROPHENYL)SULFONYL]-BETA-D-THREO-PENTOFURANOSYL]-3-[(2,4-DIMETHOXYPHENYL)METHYL]-5-METHYL-;
2,4-(1H,3H)-Pyrimidinedione, 1-[5-O-[bis(4-methoxy-phenyl)phenylmethyl]-2-deoxy-3-O-[(4-nitrophenyl)sulfonyl]-;
3-N-(2,4-Dimethoxybenzyl)-1-[5-O-(4,4''-dimethoxytrityl)-3-O-nitrophenylsulfonyl-2-deoxy-beta-D-lyxofuranosyl]thymidine;
2,4-(1H,3H)-Pyrimidinedione, 1-[5-O-[bis(4-methoxy-phenyl)phenylmethyl]-2-deoxy-3-O-[(4-nitrophenyl)sulfonyl]- beta-D-threo-pentofuranosyl]-3-[(2,4-dimethoxyphenyl)methyl]-5-methyl-;
Dimethoxybenzyl-FLT-precursor;
Dimethylbenzyl-FLT-precursor

5'-O-(4,4'-DIMETHOXYTRITYL)-2,3'-ANHYDROTHYMIDINE;
2,5-METHANO-5H,9H-PYRIMIDO[2,1-B][1,5,3]DIOXAZEPIN-9-ONE, 3-[4,4'-DIMETHOXTRITYL]-2,3-DIHYDRO-8-METHYL-, (2R,3R,5R)-;
5'-O-(4,4'-DIMETHOXYTRITYL)-2,3'-ANHYDROTHYMIDINE;
2,5-Methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one, 3-[4,4''-dimethoxtrityl]-2,3-dihydro-8-methyl-, (2R,3R,5R)-;
Anhydrothymidine-FLT-precursor;
(2R,3R,5R)-3-[[Bis(4-methoxyphenyl)phenylmethoxy]methyl]-2,3-dihydro-8-methyl-2,5-methano-5H,9H-pyrimido[2,1-b][1,5,3]dioxazepin-9-one

FETNIM-precursor;
1,3-Dioxolane-4-methanol, 2,2-dimethyl-5-[(2-nitro-1H-imidazol-1-yl)methyl]-, 4-methylbenzenesulfonate (ester), (4R-trans)-;
FETNIM-precursor

N-苯基-N-亞硝基對甲苯磺酰胺

DIAZALD(R)-N-METHYL-D3;
DIAZALD(R)-N-METHYL-D3;
N-METHYL-D3-N-NITROSO-P-TOLUENESULFONAMIDE;
N-METHYL-N-NITROSO-P-TOLUENESULFONAMIDE (N-METHYL-D3);
Diazald?N-methyl-d3;
diazald-N-methyl-D3;
DIAZALD-N-METHYL-D3, 98 ATOM % D;
(Diazomethane D2 precursor)

C8H7D3N2O3S

詳情

供應商

化工產(chǎn)品